Is Thermo Fisher Scientific Inc. (TMO) a Buy, Sell, or Hold?
Thermo Fisher Scientific Inc.
NYSE:TMO
$534.07 USD
$5.56 (1.05%)
- Volume
- 2.12M
- Average Volume
- 2.35M
- Market Capitalization
- $198.47B
- P/E Ratio
- 29.31
- Dividend Yield
- 0.34%
- Price Target
- $600.00
- Year High
- $643.99
- Year Low
- $403.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.09
- Current Ratio
- $1.53
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Marc N. Casper |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | TMO |
| CUSIP | 883556102 |
| CIK | 0000097745 |
| Web | https://www.thermofisher.com |
| Phone | 781 622 1000 |
| Currency | USD |
| Employees | 125000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.83 |
| Payout Ratio | 0.09 |
| Current Ratio | 1.53 |
| Quick Ratio | 1.15 |
| Cash Ratio | 0.22 |
Sales & Book Value
| Annual Sales | $44.56B |
| Price / Sales | 4.39 |
| Cash Flow | 18.14 |
| Price / Cash Flow | 29.41 |
| Price / Book | 3.83 |
Price Target and Rating
| Average Stock Price Forecast | $600.00 |
| High Stock Price Forecast | $683.00 |
| Low Stock Price Forecast | $490.00 |
| Forecast Upside/Downside | -10.99% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 42 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $17.74 |
| Trailing P/E Ratio | 29.31 |
| PEG Ratio | 4.48 |
| P/E Growth | 4.48 |
| Net Income | $6.74B |
| Net Margin | 15.18% |
| Pretax Margin | 16.36% |
| Return on Equity | 13.26% |
| Return on Assets | 6.05% |
Financials Score
| AltmanZ Score | 3.40 |
| Piotroski Score | 5.00 |
| Working Capital | 7.7B |
| Total Assets | 113.28B |
| Ebit | 8.66B |
| Market Cap | 196.41B |
| Total Liabilities | 61.34B |
Poll Results
About Thermo Fisher Scientific Inc. (NYSE:TMO) Stock
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a b ... road spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
TMO Fairly Valued by DCF at $478
2026-07-13 07:30:00
On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli
Thermo Fisher Scientific Announces Quarterly Dividend
2026-07-09 17:00:00
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h.
Thermo Fisher Q2 Preview: Buy Before The Recovery
2026-07-09 11:29:26
Thermo Fisher Scientific Inc. is down 12.2% YTD, underperforming both the S&P 500 and the healthcare sector. Key risks include NIH funding uncertainty, China weakness, slow organic recovery, and integration risk from the $8.9B Clario acquisition. TMO trades at an 18% discount to its 5-year average P/E, reflecting much of the downside already priced in.
2026-07-07 08:30:00
SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n.
Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy
2026-07-02 11:32:58
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is collaborating with Thermo Fisher Scientific Inc. (NYSE:TMO) to support the Phase 3 development and potential commercialization of ARCT-032, the company's investigational messenger RNA therapy for cystic fibrosis.
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
2026-07-01 08:00:00
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish.
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal
2026-06-29 04:07:10
genedrive PLC (AIM:GDR, FRA:D6M) has signed a collaboration agreement with Thermo Fisher Scientific, sending its shares up 8% to 1.4p. The point-of-care pharmacogenetic testing company will develop a high-throughput laboratory test under the deal.
2026-06-22 08:30:00
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are helping pharma and biotech customers advance innovation, simplify complex workflows and bring therapies to patients faster. Spanning AI-enabled research, clinical development and advanced manufacturing, these investments reinforce Thermo Fisher's role as a trusted strategic provider of integrated.
Frequently Asked Questions
-
What is the current Thermo Fisher Scientific Inc. (TMO) stock price?
-
Thermo Fisher Scientific Inc.(NYSE:TMO) stock price is $534.07 in the last trading session. During the trading session, TMO stock reached the peak price of $643.99 while $403.36 was the lowest point it dropped to. The percentage change in TMO stock occurred in the recent session was 1.05% while the dollar amount for the price change in TMO stock was $5.56.
-
TMO's industry and sector of operation?
-
The NYSE listed TMO is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of TMO?
-
Gianluca Pettiti | President, COO & President of Products and Technologies
Karen E. Nelson | Chief Scientific Officer
James Meyer | Senior Vice President & Chief Financial Officer
Joseph R. Holmes | Vice President & Chief Accounting Officer
Marc N. Casper | Chairman & CEO -
How many employees does TMO have?
-
Number of TMO employees currently stands at 125000. TMO operates from 168 Third Avenue, Waltham, MA 02451, US.
-
Link for TMO official website?
-
Official Website of TMO is: https://www.thermofisher.com
-
How do I contact TMO?
-
TMO could be contacted at phone #781 622 1000 and can also be accessed through its website. TMO operates from 168 Third Avenue, Waltham, MA 02451, US.
-
How many shares of TMO are traded daily?
-
The average number of TMO shares traded daily for last 3 months was 2.35M.
-
What is the market cap of TMO currently?
-
The market value of TMO currently stands at $198.47B with its latest stock price at $534.07